CIK 0001761612 · Non-accelerated filer<br>Smaller reporting company
BICYCLE THERAPEUTICS PLC
Sign in to watch- Ticker
- BCYC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 011441223261503
- Business address
- BLOCKS A & B, PORTWAY BUILDING, GRANTA PARK, GREAT ABINGTON, CAMBRIDGE, United Kingdom, CB21 6GS
- Former names
- BICYCLE THERAPEUTICS Ltd
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4/A Planned sale Chief Operating Officer sold 356 shares at an average $3.76 ($1,339)
- 4 Open-market sale Director sold 3,431 shares at $3.47 ($11,906)
- 4 Open-market sale CHIEF SCIENTIFIC OFFICER sold 2,445 shares at an average $3.49 ($8,534)
- 4 Open-market sale CHIEF PROD & SUPPLY CHAIN OFF sold 1,814 shares at an average $3.48 ($6,319)
- 4 Planned sale Chief Operating Officer sold 1,500 shares at an average $3.54 ($5,313)
- 4 Open-market sale CHIEF EXECUTIVE OFFICER sold 7,805 shares at an average $3.49 ($27,247)
- 4 Open-market sale Chief Financial Officer sold 972 shares at an average $3.48 ($3,381)
- 3/A Insider 3/A
- 144 Insider Sale of Securities
- 8-K Event Executive or director change
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Planned sale Chief Operating Officer sold 1,412 shares at an average $4.29 ($6,054)
Page 1 of 33 · 660 filings